Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 4
2018 2
2019 2
2020 4
2021 8
2022 8
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous T cell lymphoma.
Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, Geskin LJ, Quaglino P, Ramelyte E. Dummer R, et al. Among authors: ramelyte e. Nat Rev Dis Primers. 2021 Aug 26;7(1):61. doi: 10.1038/s41572-021-00296-9. Nat Rev Dis Primers. 2021. PMID: 34446710 Review.
What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S, Roggo A, Pawlik L, Dummer R, Ramelyte E. Morgenroth S, et al. Among authors: ramelyte e. Curr Oncol Rep. 2023 Nov;25(11):1397-1408. doi: 10.1007/s11912-023-01464-8. Epub 2023 Oct 24. Curr Oncol Rep. 2023. PMID: 37874473 Free PMC article. Review.
The genetic evolution of acral melanoma.
Wang M, Fukushima S, Sheen YS, Ramelyte E, Pacheco NC, Shi C, Liu S, Banik I, Aquino JD, Acosta MS, Levesque M, Dummer R, Liau JY, Chu CY, Shain AH, Yeh I, Bastian BC. Wang M, et al. Among authors: ramelyte e. bioRxiv [Preprint]. 2023 Oct 19:2023.10.18.562802. doi: 10.1101/2023.10.18.562802. bioRxiv. 2023. PMID: 37904969 Free PMC article. Preprint.
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study.
Tomsitz D, Ruf T, Heppt M, Staeger R, Ramelyte E, Dummer R, Garzarolli M, Meier F, Meier E, Richly H, Gromke T, Siveke JT, Franklin C, Klespe KC, Mauch C, Kilian T, Seegräber M, Schilling B, French LE, Berking C, Heinzerling L. Tomsitz D, et al. Among authors: ramelyte e. Cancers (Basel). 2023 Jun 30;15(13):3430. doi: 10.3390/cancers15133430. Cancers (Basel). 2023. PMID: 37444540 Free PMC article.
Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
Ramelyte E, Nägeli MC, Hunger R, Merat R, Gaide O, Navarini AA, Cozzio A, Wagner NB, Maul LV, Dummer R. Ramelyte E, et al. Dermatology. 2023;239(1):122-131. doi: 10.1159/000526478. Epub 2022 Sep 22. Dermatology. 2023. PMID: 36137524 Free PMC article. Review.
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.
Bhave P, Ahmed T, Lo SN, Shoushtari A, Zaremba A, Versluis JM, Mangana J, Weichenthal M, Si L, Lesimple T, Robert C, Trojanello C, Wicky A, Heywood R, Tran L, Batty K, Dimitriou F, Stansfeld A, Allayous C, Schwarze JK, Mooradian MJ, Klein O, Mehmi I, Roberts-Thomson R, Maurichi A, Yeoh HL, Khattak A, Zimmer L, Blank CU, Ramelyte E, Kähler KC, Roy S, Ascierto PA, Michielin O, Lorigan PC, Johnson DB, Plummer R, Lebbe C, Neyns B, Sullivan R, Hamid O, Santinami M, McArthur GA, Haydon AM, Long GV, Menzies AM, Carlino MS. Bhave P, et al. Among authors: ramelyte e. J Immunother Cancer. 2022 Jul;10(7):e004668. doi: 10.1136/jitc-2022-004668. J Immunother Cancer. 2022. PMID: 35793872 Free PMC article.
The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study.
Dummer R, Welti M, Ramelyte E. Dummer R, et al. Among authors: ramelyte e. J Transl Med. 2023 Aug 5;21(1):529. doi: 10.1186/s12967-023-04391-1. J Transl Med. 2023. PMID: 37543586 Free PMC article. Clinical Trial.
Critical aspects to achieve a high-quality melanoma clinic.
Dummer R, Ramelyte E, Levesque M, Goldinger SM, Braun RP. Dummer R, et al. Among authors: ramelyte e. Curr Opin Oncol. 2017 Mar;29(2):145-150. doi: 10.1097/CCO.0000000000000357. Curr Opin Oncol. 2017. PMID: 28027104 Free article. Review.
MEK inhibition and immune responses in advanced melanoma.
Dummer R, Ramelyte E, Schindler S, Thürigen O, Levesque MP, Koelblinger P. Dummer R, et al. Among authors: ramelyte e. Oncoimmunology. 2017 Aug 10;6(8):e1335843. doi: 10.1080/2162402X.2017.1335843. eCollection 2017. Oncoimmunology. 2017. PMID: 28919996 Free PMC article. Review.
Advances in the drug management of basal cell carcinoma.
Ramelyte E, Restivo G, Mannino M, Levesque MP, Dummer R. Ramelyte E, et al. Expert Opin Pharmacother. 2022 Apr;23(5):573-582. doi: 10.1080/14656566.2022.2032646. Epub 2022 Jan 27. Expert Opin Pharmacother. 2022. PMID: 35081851 Review.
37 results